A carregar...
Cerebrovascular Accidents Associated with Sorafenib in Hepatocellular Carcinoma
Sorafenib is an oral angiogenetic multikinase inhibitor approved in the treatment of renal and hepatocellular carcinoma. Bleeding and venous thrombotic events have been described with angiogenetic agents but cerebrovascular accidents are rarely reported. We report two cases of patients with hepatoce...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi Publishing Corporation
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3113260/ https://ncbi.nlm.nih.gov/pubmed/21687621 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/616080 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|